Rose Bengal Photodynamic Therapy (RB-PDT) Modulates the Inflammatory Response in LPS-Stimulated Human Corneal

Ning Chai1,2, Tanja Stachon1, Tim Berger3

  • 1Dr. Rolf M. Schwiete Center for Limbal Stem Cell and Aniridia Research, Saarland University, Homburg, Germany.

Current Eye Research
|April 22, 2024
PubMed
Abstract

Insights

Rose bengal photodynamic therapy reduced inflammation in human corneal fibroblasts by decreasing intercellular adhesion molecule-1 and increasing IL-6 and IL-8. This suggests involvement of the NF-κB and p38 MAPK pathways.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Immunology

Background:

  • Inflammation in human corneal fibroblasts can be triggered by lipopolysaccharide (LPS).
  • Understanding the molecular pathways involved in LPS-induced inflammation is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the effects of rose bengal photodynamic therapy (RB-PDT) on LPS-induced inflammation in human corneal fibroblasts.
  • To explore the potential involvement of mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) signaling pathways.

Main Methods:

  • Human corneal fibroblasts were stimulated with LPS and subsequently treated with RB-PDT.
  • Gene and protein expression of inflammatory markers (IL-6, IL-8, ICAM-1) were analyzed using qPCR, ELISA, and Western blot.
  • NF-κB and MAPK signaling pathway activation was assessed via qPCR and Western blot analysis of key proteins and their phosphorylation states.

Main Results:

  • RB-PDT significantly downregulated intercellular adhesion molecule-1 (ICAM-1) expression in LPS-stimulated fibroblasts.
  • RB-PDT increased the mRNA and protein levels of interleukin-6 (IL-6) and interleukin-8 (IL-8).
  • Activation of NF-κB and p38 MAPK pathways, including phosphorylation of NF-κB p65 and p38 MAPK, was observed following RB-PDT.

Conclusions:

  • RB-PDT modulates the inflammatory response in LPS-treated human corneal fibroblasts by altering IL-6, IL-8, and ICAM-1 levels.
  • The findings suggest that NF-κB and p38 MAPK pathways play a role in the mechanism of RB-PDT's anti-inflammatory effects.
  • RB-PDT shows potential as a therapeutic strategy for managing corneal inflammation.